封面
市場調查報告書
商品編碼
1733714

2026-2032 年中藥市場(依適應症/治療目的、劑型、來源、通路和地區分類)

Herbal Medicine Market By Indication/Therapeutic Use, By Form, By Source, By Distribution Channel, & Region for 2026-2032

出版日期: | 出版商: Verified Market Research | 英文 | 商品交期: 2-3個工作天內

價格
簡介目錄

中草藥市場評估-2026-2032年

消費者意識的提高和對推廣傳統藥物的投資增加正在推動草藥的採用。因此,對基於阿育吠陀和尤納尼教義的天然配方藥物的需求正在上升,預計到 2024 年市場規模將超過 1,910.6 億美元,到 2032 年將達到約 6,523 億美元的估值。

除此之外,人們越來越意識到對抗療法藥物的潛在副作用和草藥的益處,這也刺激了草藥的採用。包括藥品和補充劑在內的各個行業對草藥的採用越來越多,使得市場在 2026 年至 2032 年期間的複合年成長率達到 18.30%。

中草藥市場定義/概述

草藥是從植物的根、莖、葉、花、種子等中提取的,用於促進健康和治療疾病。常見的草藥包括銀杏、人參、生薑、薑黃和洋甘菊。幾個世紀以來,當地人一直使用這些植物來配製藥物來治療人類和動物的疾病。

草藥的用途和應用範圍十分廣泛,健康狀況和健康促進目標也多種多樣。草藥療法通常用於緩解流感、感冒、消化器官系統、頭痛和肌肉酸痛等急性疾病的相關症狀。它也用於治療關節炎、過敏、心血管疾病和精神疾病等慢性疾病。此外,醫療保健支持免疫功能、壓力管理、排毒和整體活力,在預防保健中發揮重要作用。草藥製劑可以口服、局部或吸入的方式給藥,這取決於所需的治療效果和所用草藥的特性。臨床研究證明各種草藥具有抗癌活性。本節根據這些藥物對特定癌症類型的抑製作用對其臨床使用進行分類。

銀杏是一種傳統藥草,已被證明可以治療循環系統疾病和增強記憶力,特別是在治療癡呆失智症和間歇性跛行方面。卡瓦胡椒是一種改善情緒的草藥,可能有助於治療焦慮、失眠和神經病變。然而,有人擔心卡瓦酒可能會造成肝臟病變。美國有超過 200 萬名男性使用鋸棕櫚來治療良性攝護腺增生 (BPH)。聖約翰草因其抗憂鬱症特性而聞名。

新興國家對天然藥物日益成長的需求將如何推動草藥市場的成長?

在新興國家,草藥是治療輕微疾病的必需品,常常可以取代訓練有素的醫生和藥劑師。這些藥物可生用或曬乾後製成茶、膠囊、錠劑、藥膏和糊劑,用於內部治療和治療傷口。由於新興經濟體的監管很少,草藥在這些國家被用於治療各種疾病,預計未來幾年該行業將會蓬勃發展。

草本產品電子商務銷售額的成長很大程度上得益於網路購買體驗的改善、有針對性的行銷和線上教育。亞馬遜等線上經銷商已經開發了一系列草藥產品,並根據具體情況和要求提供客製化清單的即時聊天選項和健康工具。這一趨勢歸因於網路購物體驗的改善,從而推動了市場成長。

在新冠疫情期間,封鎖和維持社交距離措施導致消費者對草藥的需求激增。人們轉向天然和有機產品(包括阿育吠陀補充劑和草藥),以及對植物藥在控制壓力和焦慮水平方面的有效性的認知不斷提高,促進了市場的成長。

政府對醫療保健互通性的投資不斷增加,刺激了醫療保健產品和服務的採用。這些資金旨在改善患者的治療效果、促進無縫資料交換並刺激醫療保健 IT 領域的創新。醫療保健支出的增加和基礎設施的進步正在支持包括草藥在內的醫療服務的擴展。這將促進草藥融入主流醫療保健,並滿足消費者對自然和替代療法的需求。

草本指南缺乏統一性是否會抑制市場成長?

由於各國法律規範不同,草藥市場面臨重大限制。草藥產品的進口、製造和標籤指南缺乏統一,使供應商和製造商的市場進入和合規變得複雜。這種分散的監管格局不僅增加了營運成本,而且由於企業需要應對不同的要求和標準,也阻礙了市場擴張。

對草藥的安全性、功效和品質的擔憂是另一個障礙。草藥成分的科學檢驗和標準化測試通訊協定有限,常常會給消費者和醫療保健從業者帶來不確定性。如果沒有強力的實證研究和監管監督,建立草藥產品的信任和接受度將會很困難,從而阻礙其更廣泛的採用和市場成長。

此外,儘管人們對自然療法的興趣日益濃厚,但由於缺乏轉診系統、資訊系統不完善以及醫療政策不協調等問題,草藥融入主流醫療保健體系的速度一直很慢。

草本市場的成長受到原料短缺、出口原料成本上升以及合成成分和益生菌等強勁競爭對手的產品替代的阻礙。此外,偽草藥產品的供應也是一個重大挑戰。

目錄

第1章 引言

  • 市場定義
  • 市場區隔
  • 調查方法

第2章執行摘要

  • 主要發現
  • 市場概覽
  • 市場亮點

第3章市場概述

  • 市場規模和成長潛力
  • 市場趨勢
  • 市場促進因素
  • 市場限制
  • 市場機會
  • 波特五力分析

第4章 中藥材市場類型

  • 錠劑和膠囊
  • 粉末
  • 膠囊和錠劑
  • 糖漿
  • 萃取物

第5章 草藥市場(依來源)

  • 葉子
  • 根和樹皮
  • 全株及果實

第6章:中藥材市場通路

  • 醫院
  • 零售藥局
  • 電子商務

第7章. 依適應症/治療用途分類的中藥市場

  • 消化器官系統健康
  • 免疫支持
  • 呼吸健康
  • 心血管健康
  • 關節和肌肉骨骼健康
  • 壓力管理/心理健康

第8章區域分析

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 智利
  • 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章市場動態

  • 市場促進因素
  • 市場限制
  • 市場機會
  • COVID-19 市場影響

第10章 競爭格局

  • 主要企業
  • 市場佔有率分析

第11章 公司簡介

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Novartis International AG
  • Bayer AG
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Sanofi SA
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Johnson & Johnson
  • Nestle SA
  • Herbalife International of America, Inc.
  • Amway Corporation
  • Nature's Sunshine Products, Inc.
  • Dabur India Ltd.
  • Himalaya Global Holdings Ltd.

第12章 市場展望市場展望與機會

  • 新興技術
  • 未來市場趨勢
  • 投資機會

第13章 附錄

  • 簡稱列表
  • 來源和參考文獻
簡介目錄
Product Code: 33183

Herbal Medicine Market Valuation - 2026-2032

The rise in consumer awareness and increased investments in promoting traditional medicine are propelling the adoption of herbal medicine. Thus, the rising demand for naturally prepared medicines based on Ayurvedic and Unani teachings has surged which is driving the market size surpass USD 191.06 Billion valued in 2024 to reach a valuation of around USD 652.3 Billion by 2032.

In addition to this, the increasing awareness of the potential negative impacts of allopathic medicines and the advantages of herbal medicinal products are spurring up the adoption of Herbal Medicine. The increasing adoption of herbal medicinal preparations has surged in various industries, including pharmaceuticals and supplements is enabling the market grow at a CAGR of 18.30% from 2026 to 2032.

Herbal Medicine Market: Definition/ Overview

Herbal medicines, derived from plants' roots, stems, leaves, flowers, or seeds, are used to improve health and treat illnesses. Popular herbs include gingko, ginseng, ginger, turmeric, and chamomile. Local communities have used these plants for centuries to prepare medicines for human and animal diseases.

The uses and applications of herbal medicine are extensive, spanning a wide range of health conditions and wellness goals. Herbal remedies are commonly used to alleviate symptoms associated with acute ailments such as flu, colds, digestive upset, headaches, and muscle pain. They are also employed for chronic conditions like arthritis, allergies, cardiovascular disease, and mental health disorders. Additionally, Herbal Medicine plays a crucial role in preventive healthcare, supporting immune function, stress management, detoxification, and overall vitality. Herbal preparations can be administered orally, topically, or through inhalation, depending on the desired therapeutic outcome and the specific properties of the herbs used. Clinical studies show a spectrum of anticancer activities from various herbal medicines. This section categorizes the clinical use of these medicines based on their suppressive effect on specific cancer types.

Ginkgo, a traditional medicine herb, has been shown to treat circulatory disorders and enhance memory, particularly in treating dementia and intermittent claudication. Kava kava, a mood-enhancing herb, may help treat anxiety, insomnia, and nervous disorders. However, there is concern that kava may cause liver damage. Saw palmetto, used by over 2 million men in the US, is used for treating benign prostatic hyperplasia (BPH). St. John's wort is known for its antidepressant effects.

How will Growing Demand for Natural Medicines in Developing Countries Drive the Growth of the Herbal Medicine Market?

Herbal medicines are crucial in developing countries for treating minor ailments, as they are often used in place of trained doctors or pharmacists. These medicines are unprocessed, dried, and used in teas, capsules, pills, salves, and poultices for internal healing and external injuries. Due to minimal regulations in developing economies, the industry is expected to grow rapidly in the coming years, as herbal medicines are used for various ailments in these countries.

The rise in herbal medicinal product sales in e-commerce is largely due to improved online purchase experiences, targeted marketing, and online education. Online distributors like Amazon have developed portfolios for herbal products, offering live chat options and wellness tools for customized lists based on specific conditions and requirements. This trend is attributed to improved online shopping experiences, this is bolstering the growth of the market

During the COVID-19 pandemic, consumer demand for herbal medicines surged due to lockdowns and social distancing measures. This shift towards natural and organic products, including Ayurveda supplements and herbal medicines, and increased awareness of botanicals' benefits in managing stress and anxiety levels contributed to market growth.

Increasing government investments in healthcare interoperability are driving the adoption of healthcare products and services. These funds aim to improve patient care outcomes, facilitate seamless data exchange, and stimulate innovation in healthcare IT. Increased healthcare expenditure and infrastructure advancements support the expansion of care delivery services, including herbal medicines. This promotes the integration of herbal medicinal products into mainstream healthcare practices, meeting consumer demand for natural and alternative treatments.

Will Lack of Uniformity in Guidelines of Herbal Medicine Restrain Its Market Growth?

The herbal medicine market faces significant constraints due to varying regulatory frameworks across different countries. Lack of uniformity in guidelines for importing, manufacturing, and labeling herbal products complicates market access and compliance for suppliers and manufacturers. This fragmented regulatory landscape not only increases operational costs but also impedes market expansion as companies navigate diverse requirements and standards.

Concerns regarding the safety, efficacy, and quality of herbal medicines pose another restraint. Limited scientific validation and standardized testing protocols for herbal ingredients often lead to uncertainty among consumers and healthcare practitioners. Without robust evidence-based research and regulatory oversight, establishing trust and acceptance in herbal products becomes challenging, hindering broader adoption and market growth.

Also, despite increasing interest in natural therapies, the integration of herbal medicines into mainstream healthcare systems is slow due to issues like lack of referral mechanisms, inadequate information systems, and uncoordinated healthcare policies.

The growth of the herbal medicine market is hindered by a shortage of raw materials and increased costs of exported ingredients, as well as product substitution, with synthetic ingredients and probiotics being strong competitors. The availability of pseudo-herbal products also poses a significant challenge.

Category-Wise Acumens

Which Factors Contributing Tablets & Capsules Segment Dominance in Herbal Medicine Market?

The tablets & capsules segment dominates the herbal medicine market due to the availability of various herbal medicines in capsules and tablets. With an increasing number of prescriptions mentioning herbal products, this segment is expected to remain dominant in the pharmaceutical industry during the forecast period.

Tablets and capsules allow for precise dosing of herbal extracts and active ingredients, ensuring consistency in therapeutic effects. This standardized format appeals to both consumers and healthcare providers seeking reliable and predictable outcomes. They have longer shelf life compared to liquid formulations, enhancing product stability and reducing wastage, benefiting manufacturers and retailers in inventory management and product availability.

Many consumers perceive tablets and capsules as more professional and medically acceptable forms of herbal medicine. This perception contributes to their popularity and widespread acceptance in the market.

Advancements in formulation technologies have enhanced the effectiveness, stability, and bioavailability of herbal ingredients in tablet and capsule formats, enhancing nutrient absorption and enhancing the delivery of herbal compounds, thus increasing their acceptance among health-conscious individuals.

Which Factors Enhance the Use of Leaves-Based Herbal Medicine?

Leaves segment is currently dominating in Herbal Medicine Market. The therapeutic properties of leaves, including their antioxidant, anti-inflammatory, and detoxifying effects, have fueled their increasing use in herbal remedies. Rich in bioactive compounds like polyphenols, flavonoids, and essential oils, leaves appeal to health-conscious consumers seeking natural alternatives.

The versatility of leaves allows for their incorporation into various herbal formulations, such as teas, extracts, tinctures, and topical preparations, addressing a wide range of health needs. This adaptability enhances their presence and dominance in the herbal medicine market.

Leaves have been used in traditional medicine systems for centuries, establishing trust and knowledge among consumers. Cultural practices and historical use continue to popularize leaves-based herbal remedies in modern healthcare. They are versatile and easy to prepare, making them suitable for consumption in teas, extracts, and dried formulations. Their mild flavors and textures make them ideal for dietary supplements and culinary applications.

Additionally, rising consumer awareness of the benefits of plant-based diets and holistic wellness practices has boosted the demand for leaves-based herbal products. This growing interest is driving market expansion and solidifying the leaves segment's leadership in the herbal medicine industry.

Country/Region-wise Acumens

Will Growing Demand for Natural And Plant-Based Therapies in Europe Mature Herbal Medicine Market?

Europe dominates the herbal medicine market due to several key factors. The region benefits from a rising geriatric population and increasing prevalence of chronic diseases, prompting a growing demand for natural and plant-based therapies as alternatives or complements to conventional medicine. This demographic shift has bolstered the adoption of herbal remedies, driving market expansion.

Increasing awareness of the benefits of herbal remedies and rising consumer preference for sustainable products. The European herbal medicine market is being driven by the growing popularity of herbal teas and supplements, the emergence of boutique brands, and the integration of herbs into functional foods and beverages. Despite regulatory challenges, consumers are seeking natural alternatives for their healthcare needs, contributing to the market's growth.

Europe's integration of traditional herbal medicines into mainstream healthcare practices contributes significantly to market dominance. Many European countries have established regulatory frameworks that support the safe and effective use of herbal products, enhancing consumer confidence and regulatory compliance.

Europe's diverse array of herbal products spans three distinct categories: prescription drugs, over-the-counter (OTC) phytomedicines, and traditional herbal remedies. This variety caters to a broad spectrum of consumer needs and preferences, offering both regulated pharmaceutical-grade treatments and traditional remedies that have gained acceptance through generations of use. This diversity and regulatory framework contribute to Europe's robust and evolving herbal medicine market.

Will Increasing Consumer Awareness about the Benefits of Natural Remedies Enhance Adoption of Herbal Medicine in Asia Pacific?

The Asia Pacific herbal medicine market is experiencing rapid growth, driven by a long history of traditional medicine, increasing consumer awareness of natural remedies, and rising healthcare costs. Traditional practices in countries like India, China, and Japan contribute to the market's growth. The region's diverse range of botanical remedies and large consumer base contribute significantly to the global market.

China is a major exporter of herbal medicines and essential oils, followed by India and Indonesia. The Chinese traditional medicines industry is supported by favorable government policies, heavy research investments, and high consumer adoption. The Chinese Journal of Traditional Chinese Medicine reports that around USS 3.0 billion worth of traditional Chinese medicines are exported annually, and over 500 million practitioners consult, accounting for around 20% of Chinese outpatient visits.

The Asia Pacific herbal medicine market has grown due to a growing interest in traditional medicine practices like Traditional Chinese Medicine (TCM) and Ayurveda. These ancient healing methods emphasize the use of herbs and natural remedies for preventive care and treatment, leading to an increased demand for herbal supplements as consumers seek natural alternatives to synthetic drugs.

Competitive Landscape

The competitive landscape of the herbal medicine market is characterized by a diverse array of players ranging from established pharmaceutical companies to traditional medicine practitioners and smaller herbal product manufacturers. These entities compete based on factors such as product quality, efficacy, safety, pricing, distribution channels, and regulatory compliance. Market dynamics are shaped by increasing consumer demand for natural and alternative therapies, stringent regulatory standards, and ongoing research and development efforts to validate the efficacy of herbal remedies. The landscape is further influenced by partnerships, strategic alliances, and investments in technological advancements aimed at enhancing the formulation, production, and distribution of herbal medicines globally. Some of the prominent players operating in the herbal medicine market include:

Himalaya Wellness

Dabur India Ltd.

Schwabe Group

Tsumura & Co.

Blackmores Ltd.

Bio-Botanica, Inc.

Nature's Bounty Co.

Ricola AG

Young Living Essential Oils

Gaia Herbs

Nutraceutical International Corporation

Arizona Natural Products

Nature's Sunshine Products

Bioforce AG (A.Vogel)

Bach Flower Remedies Ltd.

Pukka Herbs Ltd.

MediHerb (a subsidiary of Integria Healthcare)

Weleda AG

Herbalife Nutrition Ltd.

Boiron

Latest Developments

In June 2023, Traditional Medicinals, a leading North American botanical wellness company, has introduced its Organic Lemon Ginger tea in Canada. This refreshing blend, made from organic herbal ingredients like lemon peel, ginger, hibiscus, and lemongrass, offers a zesty, sweet, and slightly spicy taste, suitable for hot or cold consumption.

In January 2023, Handard, an Indian traditional medicine manufacturer, has expanded its product range to include face washes, shampoos, and oral hygiene products.

In January 2022, Blackmores Ltd., an Australian natural health and dietary supplement company, has partnered with B28 e-commerce platform Udaan to distribute its multivitamin products in India, available at independent pharmacies through Udaan.

Herbal Medicine Market, By Category

  • Form:
  • Tablets and Capsules
  • Powders
  • Capsules and Tablets
  • Syrups
  • Extracts
  • Source:
  • Leaves
  • Root and Barks
  • Whole Plants and Fruits
  • Distribution Channel:
  • Hospital
  • Retail Pharmacies
  • E-Commerce
  • Indication/Therapeutic Use:
  • Digestive Health
  • Respiratory Health
  • Cardiovascular Health
  • Joint and Musculoskeletal Health
  • Stress Management/Mental Health
  • Region:
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • Market Definition
  • Market Segmentation
  • Research Methodology

2. Executive Summary

  • Key Findings
  • Market Overview
  • Market Highlights

3. Market Overview

  • Market Size and Growth Potential
  • Market Trends
  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Porter's Five Forces Analysis

4. Herbal Medicine Market, By Form

  • Tablets and Capsules
  • Powders
  • Capsules and Tablets
  • Syrups
  • Extracts

5. Herbal Medicine Market, By Source

  • Leaves
  • Root and Barks
  • Whole Plants and Fruits

6. Herbal Medicine Market, By Distribution Channel

  • Hospital
  • Retail Pharmacies
  • E-Commerce

7. Herbal Medicine Market, By Indication/Therapeutic Use

  • Digestive Health
  • Immune Support
  • Respiratory Health
  • Cardiovascular Health
  • Joint and Musculoskeletal Health
  • Stress Management/Mental Health

8. Regional Analysis

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Latin America
  • Brazil
  • Argentina
  • Chile
  • Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

9. Market Dynamics

  • Market Drivers
  • Market Restraints
  • Market Opportunities
  • Impact of COVID-19 on the Market

10. Competitive Landscape

  • Key Players
  • Market Share Analysis

11. Company Profiles

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Novartis International AG
  • Bayer AG
  • Pfizer Inc.
  • GlaxoSmithKline plc.
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Johnson & Johnson
  • Nestle S.A.
  • Herbalife International of America, Inc.
  • Amway Corporation
  • Nature's Sunshine Products, Inc.
  • Dabur India Ltd.
  • Himalaya Global Holdings Ltd.

12. Market Outlook and Opportunities

  • Emerging Technologies
  • Future Market Trends
  • Investment Opportunities

13. Appendix

  • List of Abbreviations
  • Sources and References